iCAD ProFound AI

Paragraph 1: iCAD’s ProFound AI Breast Health Suite is a clinically proven, AI-powered set of solutions for cancer detection, density assessment, and risk evaluation. It is designed to help radiologists and clinicians personalize breast cancer screening and improve patient outcomes. The suite emphasizes integration with existing workflows and multi-vendor compatibility, supported by extensive data and regulatory approvals.

Paragraph 2: The ProFound suite is built to integrate rapidly into practice, with flexible deployment options and workflow integration. It targets healthcare providers who perform breast imaging and screening, aiming to streamline reads, reduce recalls, and support clinicians in identifying areas of concern across 2D and 3D mammography.

Paragraph 3: Its core components—Detection, Density, and Risk—provide a comprehensive approach to screening. Detection focuses on spotting cancers earlier with high accuracy, Density standardizes density reporting, and Risk assesses short-term cancer risk using image-derived data. The platform claims to offer faster reads, improved diagnostic confidence, and a data-driven basis for personalized care.

Paragraph 4: The product notes that ProFound AI solutions are certified and available in over 50 countries and can be deployed via cloud or on-premises options, with a focus on interoperability and regulatory compliance. It also highlights ongoing clinical validation and partnerships to support deployment across diverse healthcare settings.